You are here:

Meda Pharmaceuticals Ltd

Name SMC ID No Status Sub. Type
 
azelastine hydrochloride + fluticasone propionate (Dymista) 921/13 Accepted Abbreviated Submission
azelastine hydrochloride plus fluticasone propionate (Dymista) 921/13 Not Recommended Abbreviated Submission
budesonide 200mcg (Novolizer®) inhaler 306/06 Accepted Abbreviated Submission
calcium carbonate + cholecalciferol (Kalcipos-D®) 718/11 Accepted Abbreviated Submission
clindamycin 1% / tretinoin 0.025% gel (Treclin®) 1010/14 Accepted Abbreviated Submission
colecalciferol (Desunin) 840/13 Accepted Abbreviated Submission
fentanyl citrate (Breakyl) 947/13 Not Recommended Non submission
flecainide 200mg caps (Tambocor XL) 521/08 Accepted Abbreviated Submission
histamine dihydrochloride (Ceplene) 666/10 Not Recommended Full submission
imiquimod (Zyclara) 934/13 Not Recommended Non submission
imiquimod 5% cream (Aldara) 385/07 Not Recommended Full submission
imiquimod 5% cream (Aldara) 385/07 Restricted Resubmission
ketoprofen / omeprazole (Axorid) 606/10 Accepted Resubmission
ketoprofen / omeprazole (Axorid) 606/10 Full submission
salbutamol sulphate (Salbulin MDPI Novoliser) 504/08 Accepted Abbreviated Submission

Back